Summary
According to APO Research, The global Embolotherapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Embolotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Embolotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Embolotherapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Embolotherapy, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Embolotherapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Embolotherapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Embolotherapy revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Embolotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Embolotherapy revenue, projected growth trends, production technology, application and end-user industry.
Embolotherapy segment by Company
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Embolotherapy segment by Type
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Embolotherapy segment by Application
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Embolotherapy segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Embolotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Embolotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolotherapy revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Embolotherapy Market by Type
1.2.1 Global Embolotherapy Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Microspheres for Embolization
1.2.3 Embolism Particles
1.2.4 Embolic coils
1.2.5 Liquid Embolic Agent
1.2.6 Auxiliary Embolization Material
1.2.7 Others
1.3 Embolotherapy Market by Application
1.3.1 Global Embolotherapy Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Peripheral Aascular Disease
1.3.4 Nerve System Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Embolotherapy Market Dynamics
2.1 Embolotherapy Industry Trends
2.2 Embolotherapy Industry Drivers
2.3 Embolotherapy Industry Opportunities and Challenges
2.4 Embolotherapy Industry Restraints
3 Global Growth Perspective
3.1 Global Embolotherapy Market Perspective (2019-2030)
3.2 Global Embolotherapy Growth Trends by Region
3.2.1 Global Embolotherapy Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Embolotherapy Market Size by Region (2019-2024)
3.2.3 Global Embolotherapy Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Embolotherapy Revenue by Players
4.1.1 Global Embolotherapy Revenue by Players (2019-2024)
4.1.2 Global Embolotherapy Revenue Market Share by Players (2019-2024)
4.1.3 Global Embolotherapy Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Embolotherapy Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Embolotherapy Key Players Headquarters & Area Served
4.4 Global Embolotherapy Players, Product Type & Application
4.5 Global Embolotherapy Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Embolotherapy Market CR5 and HHI
4.6.2 Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2023
4.6.3 2023 Embolotherapy Tier 1, Tier 2, and Tier 3
5 Embolotherapy Market Size by Type
5.1 Global Embolotherapy Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Embolotherapy Revenue by Type (2019-2030)
5.3 Global Embolotherapy Revenue Market Share by Type (2019-2030)
6 Embolotherapy Market Size by Application
6.1 Global Embolotherapy Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Embolotherapy Revenue by Application (2019-2030)
6.3 Global Embolotherapy Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Comapny Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Embolotherapy Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Embolotherapy Product Portfolio
7.1.5 Medtronic Recent Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Comapny Information
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific Embolotherapy Revenue and Gross Margin (2019-2024)
7.2.4 Boston Scientific Embolotherapy Product Portfolio
7.2.5 Boston Scientific Recent Developments
7.3 Terumo
7.3.1 Terumo Comapny Information
7.3.2 Terumo Business Overview
7.3.3 Terumo Embolotherapy Revenue and Gross Margin (2019-2024)
7.3.4 Terumo Embolotherapy Product Portfolio
7.3.5 Terumo Recent Developments
7.4 Penumbra, Inc.
7.4.1 Penumbra, Inc. Comapny Information
7.4.2 Penumbra, Inc. Business Overview
7.4.3 Penumbra, Inc. Embolotherapy Revenue and Gross Margin (2019-2024)
7.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
7.4.5 Penumbra, Inc. Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Comapny Information
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Embolotherapy Revenue and Gross Margin (2019-2024)
7.5.4 Johnson & Johnson Embolotherapy Product Portfolio
7.5.5 Johnson & Johnson Recent Developments
7.6 Sirtex
7.6.1 Sirtex Comapny Information
7.6.2 Sirtex Business Overview
7.6.3 Sirtex Embolotherapy Revenue and Gross Margin (2019-2024)
7.6.4 Sirtex Embolotherapy Product Portfolio
7.6.5 Sirtex Recent Developments
7.7 Merit Medical
7.7.1 Merit Medical Comapny Information
7.7.2 Merit Medical Business Overview
7.7.3 Merit Medical Embolotherapy Revenue and Gross Margin (2019-2024)
7.7.4 Merit Medical Embolotherapy Product Portfolio
7.7.5 Merit Medical Recent Developments
7.8 Varian
7.8.1 Varian Comapny Information
7.8.2 Varian Business Overview
7.8.3 Varian Embolotherapy Revenue and Gross Margin (2019-2024)
7.8.4 Varian Embolotherapy Product Portfolio
7.8.5 Varian Recent Developments
7.9 Stryker
7.9.1 Stryker Comapny Information
7.9.2 Stryker Business Overview
7.9.3 Stryker Embolotherapy Revenue and Gross Margin (2019-2024)
7.9.4 Stryker Embolotherapy Product Portfolio
7.9.5 Stryker Recent Developments
7.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
7.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Comapny Information
7.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
7.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue and Gross Margin (2019-2024)
7.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
7.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
7.11 Cook Medical
7.11.1 Cook Medical Comapny Information
7.11.2 Cook Medical Business Overview
7.11.3 Cook Medical Embolotherapy Revenue and Gross Margin (2019-2024)
7.11.4 Cook Medical Embolotherapy Product Portfolio
7.11.5 Cook Medical Recent Developments
7.12 Kaneka
7.12.1 Kaneka Comapny Information
7.12.2 Kaneka Business Overview
7.12.3 Kaneka Embolotherapy Revenue and Gross Margin (2019-2024)
7.12.4 Kaneka Embolotherapy Product Portfolio
7.12.5 Kaneka Recent Developments
7.13 Meril Life Sciences
7.13.1 Meril Life Sciences Comapny Information
7.13.2 Meril Life Sciences Business Overview
7.13.3 Meril Life Sciences Embolotherapy Revenue and Gross Margin (2019-2024)
7.13.4 Meril Life Sciences Embolotherapy Product Portfolio
7.13.5 Meril Life Sciences Recent Developments
7.14 Peijia Medical Limited
7.14.1 Peijia Medical Limited Comapny Information
7.14.2 Peijia Medical Limited Business Overview
7.14.3 Peijia Medical Limited Embolotherapy Revenue and Gross Margin (2019-2024)
7.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
7.14.5 Peijia Medical Limited Recent Developments
7.15 Wallaby Medical
7.15.1 Wallaby Medical Comapny Information
7.15.2 Wallaby Medical Business Overview
7.15.3 Wallaby Medical Embolotherapy Revenue and Gross Margin (2019-2024)
7.15.4 Wallaby Medical Embolotherapy Product Portfolio
7.15.5 Wallaby Medical Recent Developments
7.16 MicroPort Scientific Corporation
7.16.1 MicroPort Scientific Corporation Comapny Information
7.16.2 MicroPort Scientific Corporation Business Overview
7.16.3 MicroPort Scientific Corporation Embolotherapy Revenue and Gross Margin (2019-2024)
7.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
7.16.5 MicroPort Scientific Corporation Recent Developments
7.17 Shandong Visee Medical Devices Co.,Ltd
7.17.1 Shandong Visee Medical Devices Co.,Ltd Comapny Information
7.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
7.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue and Gross Margin (2019-2024)
7.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
7.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
7.18 Beijing Taijie Weiye Technology
7.18.1 Beijing Taijie Weiye Technology Comapny Information
7.18.2 Beijing Taijie Weiye Technology Business Overview
7.18.3 Beijing Taijie Weiye Technology Embolotherapy Revenue and Gross Margin (2019-2024)
7.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
7.18.5 Beijing Taijie Weiye Technology Recent Developments
8 North America
8.1 North America Embolotherapy Revenue (2019-2030)
8.2 North America Embolotherapy Revenue by Type (2019-2030)
8.2.1 North America Embolotherapy Revenue by Type (2019-2024)
8.2.2 North America Embolotherapy Revenue by Type (2025-2030)
8.3 North America Embolotherapy Revenue Share by Type (2019-2030)
8.4 North America Embolotherapy Revenue by Application (2019-2030)
8.4.1 North America Embolotherapy Revenue by Application (2019-2024)
8.4.2 North America Embolotherapy Revenue by Application (2025-2030)
8.5 North America Embolotherapy Revenue Share by Application (2019-2030)
8.6 North America Embolotherapy Revenue by Country
8.6.1 North America Embolotherapy Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Embolotherapy Revenue by Country (2019-2024)
8.6.3 North America Embolotherapy Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Embolotherapy Revenue (2019-2030)
9.2 Europe Embolotherapy Revenue by Type (2019-2030)
9.2.1 Europe Embolotherapy Revenue by Type (2019-2024)
9.2.2 Europe Embolotherapy Revenue by Type (2025-2030)
9.3 Europe Embolotherapy Revenue Share by Type (2019-2030)
9.4 Europe Embolotherapy Revenue by Application (2019-2030)
9.4.1 Europe Embolotherapy Revenue by Application (2019-2024)
9.4.2 Europe Embolotherapy Revenue by Application (2025-2030)
9.5 Europe Embolotherapy Revenue Share by Application (2019-2030)
9.6 Europe Embolotherapy Revenue by Country
9.6.1 Europe Embolotherapy Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Embolotherapy Revenue by Country (2019-2024)
9.6.3 Europe Embolotherapy Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Embolotherapy Revenue (2019-2030)
10.2 China Embolotherapy Revenue by Type (2019-2030)
10.2.1 China Embolotherapy Revenue by Type (2019-2024)
10.2.2 China Embolotherapy Revenue by Type (2025-2030)
10.3 China Embolotherapy Revenue Share by Type (2019-2030)
10.4 China Embolotherapy Revenue by Application (2019-2030)
10.4.1 China Embolotherapy Revenue by Application (2019-2024)
10.4.2 China Embolotherapy Revenue by Application (2025-2030)
10.5 China Embolotherapy Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Embolotherapy Revenue (2019-2030)
11.2 Asia Embolotherapy Revenue by Type (2019-2030)
11.2.1 Asia Embolotherapy Revenue by Type (2019-2024)
11.2.2 Asia Embolotherapy Revenue by Type (2025-2030)
11.3 Asia Embolotherapy Revenue Share by Type (2019-2030)
11.4 Asia Embolotherapy Revenue by Application (2019-2030)
11.4.1 Asia Embolotherapy Revenue by Application (2019-2024)
11.4.2 Asia Embolotherapy Revenue by Application (2025-2030)
11.5 Asia Embolotherapy Revenue Share by Application (2019-2030)
11.6 Asia Embolotherapy Revenue by Country
11.6.1 Asia Embolotherapy Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Embolotherapy Revenue by Country (2019-2024)
11.6.3 Asia Embolotherapy Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Embolotherapy Revenue (2019-2030)
12.2 MEALA Embolotherapy Revenue by Type (2019-2030)
12.2.1 MEALA Embolotherapy Revenue by Type (2019-2024)
12.2.2 MEALA Embolotherapy Revenue by Type (2025-2030)
12.3 MEALA Embolotherapy Revenue Share by Type (2019-2030)
12.4 MEALA Embolotherapy Revenue by Application (2019-2030)
12.4.1 MEALA Embolotherapy Revenue by Application (2019-2024)
12.4.2 MEALA Embolotherapy Revenue by Application (2025-2030)
12.5 MEALA Embolotherapy Revenue Share by Application (2019-2030)
12.6 MEALA Embolotherapy Revenue by Country
12.6.1 MEALA Embolotherapy Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Embolotherapy Revenue by Country (2019-2024)
12.6.3 MEALA Embolotherapy Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Embolotherapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Microspheres for Embolization Major Manufacturers
Table 2. Embolism Particles Major Manufacturers
Table 3. Embolic coils Major Manufacturers
Table 4. Liquid Embolic Agent Major Manufacturers
Table 5. Auxiliary Embolization Material Major Manufacturers
Table 6. Others Major Manufacturers
Table 7. Global Embolotherapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Cancer Major Manufacturers
Table 9. Peripheral Aascular Disease Major Manufacturers
Table 10. Nerve System Disease Major Manufacturers
Table 11. Others Major Manufacturers
Table 12. Embolotherapy Industry Trends
Table 13. Embolotherapy Industry Drivers
Table 14. Embolotherapy Industry Opportunities and Challenges
Table 15. Embolotherapy Industry Restraints
Table 16. Global Embolotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Embolotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 18. Global Embolotherapy Market Share by Region (2019-2024)
Table 19. Global Embolotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 20. Global Embolotherapy Market Share by Region (2025-2030)
Table 21. Global Embolotherapy Revenue by Players (US$ Million) & (2019-2024)
Table 22. Global Embolotherapy Revenue Market Share by Players (2019-2024)
Table 23. Global Embolotherapy Key Players Ranking, 2022 VS 2023 VS 2024
Table 24. Global Embolotherapy Key Players Headquarters & Area Served
Table 25. Global Embolotherapy Players, Product Type & Application
Table 26. Global Embolotherapy Players Commercialization Time
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Embolotherapy by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Global Embolotherapy Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 31. Global Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Table 32. Global Embolotherapy Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 33. Global Embolotherapy Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 34. Global Embolotherapy Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 36. Global Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Table 37. Global Embolotherapy Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 38. Global Embolotherapy Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 39. Medtronic Company Information
Table 40. Medtronic Business Overview
Table 41. Medtronic Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Medtronic Embolotherapy Product Portfolio
Table 43. Medtronic Recent Development
Table 44. Boston Scientific Company Information
Table 45. Boston Scientific Business Overview
Table 46. Boston Scientific Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Boston Scientific Embolotherapy Product Portfolio
Table 48. Boston Scientific Recent Development
Table 49. Terumo Company Information
Table 50. Terumo Business Overview
Table 51. Terumo Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Terumo Embolotherapy Product Portfolio
Table 53. Terumo Recent Development
Table 54. Penumbra, Inc. Company Information
Table 55. Penumbra, Inc. Business Overview
Table 56. Penumbra, Inc. Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Penumbra, Inc. Embolotherapy Product Portfolio
Table 58. Penumbra, Inc. Recent Development
Table 59. Johnson & Johnson Company Information
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Johnson & Johnson Embolotherapy Product Portfolio
Table 63. Johnson & Johnson Recent Development
Table 64. Sirtex Company Information
Table 65. Sirtex Business Overview
Table 66. Sirtex Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Sirtex Embolotherapy Product Portfolio
Table 68. Sirtex Recent Development
Table 69. Merit Medical Company Information
Table 70. Merit Medical Business Overview
Table 71. Merit Medical Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Merit Medical Embolotherapy Product Portfolio
Table 73. Merit Medical Recent Development
Table 74. Varian Company Information
Table 75. Varian Business Overview
Table 76. Varian Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Varian Embolotherapy Product Portfolio
Table 78. Varian Recent Development
Table 79. Stryker Company Information
Table 80. Stryker Business Overview
Table 81. Stryker Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Stryker Embolotherapy Product Portfolio
Table 83. Stryker Recent Development
Table 84. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
Table 85. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
Table 86. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 87. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
Table 88. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development
Table 89. Cook Medical Company Information
Table 90. Cook Medical Business Overview
Table 91. Cook Medical Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Cook Medical Embolotherapy Product Portfolio
Table 93. Cook Medical Recent Development
Table 94. Kaneka Company Information
Table 95. Kaneka Business Overview
Table 96. Kaneka Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Kaneka Embolotherapy Product Portfolio
Table 98. Kaneka Recent Development
Table 99. Meril Life Sciences Company Information
Table 100. Meril Life Sciences Business Overview
Table 101. Meril Life Sciences Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Meril Life Sciences Embolotherapy Product Portfolio
Table 103. Meril Life Sciences Recent Development
Table 104. Peijia Medical Limited Company Information
Table 105. Peijia Medical Limited Business Overview
Table 106. Peijia Medical Limited Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Peijia Medical Limited Embolotherapy Product Portfolio
Table 108. Peijia Medical Limited Recent Development
Table 109. Wallaby Medical Company Information
Table 110. Wallaby Medical Business Overview
Table 111. Wallaby Medical Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Wallaby Medical Embolotherapy Product Portfolio
Table 113. Wallaby Medical Recent Development
Table 114. MicroPort Scientific Corporation Company Information
Table 115. MicroPort Scientific Corporation Business Overview
Table 116. MicroPort Scientific Corporation Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. MicroPort Scientific Corporation Embolotherapy Product Portfolio
Table 118. MicroPort Scientific Corporation Recent Development
Table 119. Shandong Visee Medical Devices Co.,Ltd Company Information
Table 120. Shandong Visee Medical Devices Co.,Ltd Business Overview
Table 121. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
Table 123. Shandong Visee Medical Devices Co.,Ltd Recent Development
Table 124. Beijing Taijie Weiye Technology Company Information
Table 125. Beijing Taijie Weiye Technology Business Overview
Table 126. Beijing Taijie Weiye Technology Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
Table 128. Beijing Taijie Weiye Technology Recent Development
Table 129. North America Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 130. North America Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 131. North America Embolotherapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 132. North America Embolotherapy Revenue by Country (2019-2024) & (US$ Million)
Table 133. North America Embolotherapy Revenue by Country (2025-2030) & (US$ Million)
Table 134. Europe Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 135. Europe Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 136. Europe Embolotherapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 137. Europe Embolotherapy Revenue by Country (2019-2024) & (US$ Million)
Table 138. Europe Embolotherapy Revenue by Country (2025-2030) & (US$ Million)
Table 139. China Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 140. China Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 141. Asia Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 142. Asia Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 143. Asia Embolotherapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 144. Asia Embolotherapy Revenue by Country (2019-2024) & (US$ Million)
Table 145. Asia Embolotherapy Revenue by Country (2025-2030) & (US$ Million)
Table 146. MEALA Embolotherapy Revenue by Type (2019-2024) & (US$ Million)
Table 147. MEALA Embolotherapy Revenue by Application (2019-2024) & (US$ Million)
Table 148. MEALA Embolotherapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. MEALA Embolotherapy Revenue by Country (2019-2024) & (US$ Million)
Table 150. MEALA Embolotherapy Revenue by Country (2025-2030) & (US$ Million)
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources
List of Figures
Figure 1. Embolotherapy Product Picture
Figure 2. Global Embolotherapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Embolotherapy Market Size Share 2019 VS 2023 VS 2030
Figure 4. Microspheres for Embolization Picture
Figure 5. Embolism Particles Picture
Figure 6. Embolic coils Picture
Figure 7. Liquid Embolic Agent Picture
Figure 8. Auxiliary Embolization Material Picture
Figure 9. Others Picture
Figure 10. Global Embolotherapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Embolotherapy Market Size Share 2019 VS 2023 VS 2030
Figure 12. Cancer Picture
Figure 13. Peripheral Aascular Disease Picture
Figure 14. Nerve System Disease Picture
Figure 15. Others Picture
Figure 16. Global Embolotherapy Market Size (US$ Million) & (2019-2030)
Figure 17. Global Embolotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Embolotherapy Market Share by Region: 2019 VS 2023 VS 2030
Figure 19. Global Embolotherapy Players Revenue Share Top 10 and Top 5 in 2023
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Embolotherapy Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Embolotherapy Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Embolotherapy Revenue Market Share by Type (2019-2030)
Figure 24. Global Embolotherapy Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Embolotherapy Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 26. Global Embolotherapy Revenue Market Share by Application (2019-2030)
Figure 27. North America Embolotherapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 28. North America Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Figure 29. North America Embolotherapy Revenue Share by Type (2019-2030)
Figure 30. North America Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Figure 31. North America Embolotherapy Revenue Share by Application (2019-2030)
Figure 32. North America Embolotherapy Revenue Share by Country (2019-2030)
Figure 33. United States Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 34. Canada Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 35. Europe Embolotherapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 36. Europe Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Figure 37. Europe Embolotherapy Revenue Share by Type (2019-2030)
Figure 38. Europe Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Figure 39. Europe Embolotherapy Revenue Share by Application (2019-2030)
Figure 40. Europe Embolotherapy Revenue Share by Country (2019-2030)
Figure 41. Germany Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. France Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. U.K. Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Italy Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. Russia Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. Nordic Countries Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 47. China Embolotherapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Figure 49. China Embolotherapy Revenue Share by Type (2019-2030)
Figure 50. China Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Figure 51. China Embolotherapy Revenue Share by Application (2019-2030)
Figure 52. Asia Embolotherapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 53. Asia Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Figure 54. Asia Embolotherapy Revenue Share by Type (2019-2030)
Figure 55. Asia Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Figure 56. Asia Embolotherapy Revenue Share by Application (2019-2030)
Figure 57. Asia Embolotherapy Revenue Share by Country (2019-2030)
Figure 58. Japan Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. South Korea Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. India Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. Australia Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. China Taiwan Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. Southeast Asia Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 64. MEALA Embolotherapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 65. MEALA Embolotherapy Revenue by Type (2025-2030) & (US$ Million)
Figure 66. MEALA Embolotherapy Revenue Share by Type (2019-2030)
Figure 67. MEALA Embolotherapy Revenue by Application (2025-2030) & (US$ Million)
Figure 68. MEALA Embolotherapy Revenue Share by Application (2019-2030)
Figure 69. MEALA Embolotherapy Revenue Share by Country (2019-2030)
Figure 70. Mexico Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. South Korea Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Brazil Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Israel Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Argentina Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Colombia Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Turkey Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Saudi Arabia Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. UAE Embolotherapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 79. Years Considered
Figure 80. Research Process
Figure 81. Key Executives Interviewed
